1-(3-(4-Amino-5-(benzo[b]thiophen-2-yl)-7H-pyrrolo[2,3-d]-pyrimidin-7-yl)azetidin-1-yl)prop-2-en-1-one

ID: ALA4521898

PubChem CID: 132246037

Max Phase: Preclinical

Molecular Formula: C20H17N5OS

Molecular Weight: 375.46

Molecule Type: Unknown

Associated Items:

This compound is not in our inventory system

Names and Identifiers

Canonical SMILES:  C=CC(=O)N1CC(n2cc(-c3cc4ccccc4s3)c3c(N)ncnc32)C1

Standard InChI:  InChI=1S/C20H17N5OS/c1-2-17(26)24-8-13(9-24)25-10-14(18-19(21)22-11-23-20(18)25)16-7-12-5-3-4-6-15(12)27-16/h2-7,10-11,13H,1,8-9H2,(H2,21,22,23)

Standard InChI Key:  HLRISBLSHWIQBN-UHFFFAOYSA-N

Molfile:  

 
     RDKit          2D

 27 31  0  0  0  0  0  0  0  0999 V2000
   37.2097  -13.4712    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   37.2085  -14.2949    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   37.9207  -14.7039    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   37.9189  -13.0582    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   38.6317  -13.4676    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   38.6365  -14.2904    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   39.4206  -14.5388    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   39.8980  -13.8696    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   39.4129  -13.2061    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   37.9165  -12.2369    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   39.6608  -12.4233    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   40.4381  -12.1667    0.0000 S   0  0  0  0  0  0  0  0  0  0  0  0
   39.1700  -11.7614    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   39.6505  -11.0974    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   40.4315  -11.3463    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   41.0376  -10.7943    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   40.8598   -9.9933    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   40.0745   -9.7472    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   39.4759  -10.3009    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   39.6763  -15.3149    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   39.3096  -16.0492    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   40.0398  -16.4160    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   40.4107  -15.6816    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   40.2529  -17.2064    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   39.6697  -17.7872    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   41.0459  -17.4196    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   41.6249  -16.8430    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  2  0
  2  3  1  0
  3  6  2  0
  5  4  2  0
  4  1  1  0
  5  6  1  0
  6  7  1  0
  7  8  1  0
  8  9  2  0
  9  5  1  0
  4 10  1  0
  9 11  1  0
 11 12  1  0
 12 15  1  0
 14 13  1  0
 13 11  2  0
 14 15  2  0
 15 16  1  0
 16 17  2  0
 17 18  1  0
 18 19  2  0
 19 14  1  0
 20 21  1  0
 21 22  1  0
 22 23  1  0
 23 20  1  0
  7 20  1  0
 22 24  1  0
 24 25  2  0
 24 26  1  0
 26 27  2  0
M  END

Alternative Forms

  1. Parent:

    ALA4521898

    ---

Associated Targets(Human)

FGFR4 Tclin Fibroblast growth factor receptor 4 (3668 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
FGFR1 Tclin Fibroblast growth factor receptor 1 (9149 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
NCI-H1581 (382 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: UnknownTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 375.46Molecular Weight (Monoisotopic): 375.1154AlogP: 3.46#Rotatable Bonds: 3
Polar Surface Area: 77.04Molecular Species: NEUTRALHBA: 6HBD: 1
#RO5 Violations: HBA (Lipinski): 6HBD (Lipinski): 2#RO5 Violations (Lipinski):
CX Acidic pKa: CX Basic pKa: 6.46CX LogP: 2.92CX LogD: 2.87
Aromatic Rings: 4Heavy Atoms: 27QED Weighted: 0.56Np Likeness Score: -0.67

References

1. Wang Y, Li L, Fan J, Dai Y, Jiang A, Geng M, Ai J, Duan W..  (2018)  Discovery of Potent Irreversible Pan-Fibroblast Growth Factor Receptor (FGFR) Inhibitors.,  61  (20): [PMID:29522671] [10.1021/acs.jmedchem.7b01843]

Source